Rosine Luo has nearly 8 years of experience in investment and possesses proficiency in financial analysis, conducting due diligence, and deal execution processes. She joined BOCG in 2016 and has been actively involved in numerous investments, including Boan Biotech, Koka Lifesciences, Signet Therapeutics, InterHill MED and Recovery plus. Prior to joining BOCG, she worked as an analyst at Youjoy Capital and Bank of China. She earned a bachelor's degree in Finance from Duquesne University, USA.